Drug Discovery - Yokogawa CQ3000 High Content Imager - Winner of the 2024 Pharma Innovation Award
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

Can you go beyond intrinsic DILI predictions in vitro?Can you go beyond intrinsic DILI predictions in vitro?

Rapidly adopt an Organ-on-a-chip approach and bridge the relevance gap between traditional in vitro assay and first-in-human studies with the all-in-one PhysioMimix® DILI assay kit: Human 24.

Read the Appnote, featuring troglitazone and amiodarone, to find out how the kit delivers mechanistic signatures of hepatotoxicity, including complex and immune-related effects.

Get the App Note
 
 
    Yokogawa CQ3000 High Content Imager - Winner of the 2024 Pharma Innovation AwardYokogawa CQ3000 High Content Imager - Winner of the 2024 Pharma Innovation Award
 
The award-winning Yokogawa CQ3000 High Content Imager transforms cellular research with cutting-edge imaging technology. High-NA immersion lenses ensure superior resolution, while dual-channel, parallel imaging boosts throughput. Great environmental control and robust design, too! Perfect for today’s 3D assays, the CQ3000 offers laser-driven, dual spinning disk technology at its most affordable.
 
Learn More
 
 
   British scientists unveil world-leading technology to speed up drug discoveryBritish scientists unveil world-leading technology to speed up drug discovery
 
A new 3D bio-printer that produces human-like tissue holds the potential to revolutionize the discovery of new drugs for cancer, heart disease and arthritis.
 
   Clinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injuryClinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injury
 
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.
 
 New clinical trial aims to optimize pain management and reduce opioid use after mastectomy
 
New clinical trial aims to optimize pain management and reduce opioid use after mastectomyA multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy procedures.
 
 
 New clinical trial tests 3D-printed devices for treating tracheobronchomalacia in infants
 
New clinical trial tests 3D-printed devices for treating tracheobronchomalacia in infantsA new clinical trial will allow researchers to study 3D-printed bioresorbable devices aimed at treating children with rare and life-threatening airway condition tracheobronchomalacia.
 
 
 Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial
 
Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trialResearchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.
 
 
 BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics
 
BIOVECTRA is honored with 2025 CDMO Leadership Award for biologicsBIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 Outsourced Pharma CDMO Leadership Award in the category of biologics.
 
 
 Clinical trial of vaccine candidate to prevent Lassa fever begins enrollment
 
Clinical trial of vaccine candidate to prevent Lassa fever begins enrollmentA National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.
 
 
 Clinical trial investigates osteoporosis medication for type 1 diabetes
 
Clinical trial investigates osteoporosis medication for type 1 diabetesCity of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is leading a phase 1/2 clinical trial investigating an osteoporosis medication as a way to improve beta cell health in people with early type 1 diabetes.
 
 
 Accelerating Drug Discovery and Development with Effective Data Housekeeping
 
Accelerating Drug Discovery and Development with Effective Data HousekeepingEffective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and patient outcomes in healthcare.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025